Lexaria Bioscience Corp. (LEXX)
0.957
+0.01
(+1.50%)
USD |
NASDAQ |
Apr 24, 16:00
0.957
0.00 (0.00%)
After-Hours: 20:00
Lexaria Bioscience EPS Diluted (Quarterly) : -0.0593 for Feb. 28, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.0139 |
| Aurinia Pharmaceuticals, Inc. | 1.526 |
| Edesa Biotech, Inc. | -0.2819 |
| Xenon Pharmaceuticals, Inc. | -1.314 |
| ProMIS Neurosciences, Inc. | -4.959 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.453M |
| Revenue (Quarterly) | 0.02M |
| Total Expenses (Quarterly) | 1.47M |
| Enterprise Value | 17.80M |
| Gross Profit Margin (Quarterly) | -33.00% |
| Profit Margin (Quarterly) | -7.26K% |
| Earnings Yield | -50.03% |
| Normalized Earnings Yield | -48.96 |